Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

NCT03595917

Conditions
B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Burkitt Lymphoma, +27 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

HPC Offered for PRESERVE Expansion

NCT07145411

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +31 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Henry Ford Health Detroit, Michigan, United States
  • The Ohio State University Medical Center Columbus, Ohio, United States
  • Tristar Centennial Medical Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

NCT04838041

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, +12 more
Locations
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

NCT06409936

Conditions
Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +15 more
Locations
  • Hospital del Mar (Barcelona) Barcelona, Spain
  • Hospital Universitario Basurto Bilbao, Spain
  • Institut Català d'Oncologia Girona Girona, Spain
  • Hospital Virgen de las Nieves Granada, Spain
View Trial Details

Related conditions